NKTT120 Archives - Biotech Primer WEEKLY

Sculpting A Better Life For Sickle Cell Patients

by Stacey Hawkins | Oct 16, 2014 | Genetic Disease

With the recent announcement of two new biologics in Phase I studies for Sickle Cell Disease (SCD), WEEKLY takes a closer look at the treatments for this autosomal recessive disease, afflicting approximately 100,000 Americans and 25 million globally. Sickle cell...

Sculpting A Better Life For Sickle Cell Patients

About Biotech Primer

Subscribe to The WEEKLY